ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
매크로라이드계 항생제 시장 규모는 향후 몇 년 동안 연평균 11.5%의 성장률(CAGR)로 2029년 1,020억 9,000만 달러에 달할 것으로 예상됩니다. 예측 기간의 성장은 호흡기 감염증의 발생 증가, 병용요법 증가, 전 세계 노인 인구 증가, 인식 개선 및 진단, 원격의료 및 온라인 약국 서비스 성장 등의 요인으로 인한 호흡기 감염증의 증가에 기인하는 것으로 추정됩니다. 예측 기간 동안 주요 동향으로는 약물전달 시스템 및 제형의 발전, 신규 매크로라이드계 항생제 개발, 원격의료 및 원격 헬스케어 서비스 발전, 매크로라이드계 항생제의 친환경적 제조 공정 개발 등을 들 수 있습니다.
매크로라이드계 항생제 시장의 성장은 향후 몇 년 동안 피부 감염의 유병률 증가에 의해 주도될 것으로 예상됩니다. 피부 감염은 유해한 미생물이 피부에 침입하여 염증을 유발하는 것으로, 발적, 부종, 통증 등의 증상을 동반하는 경우가 많습니다. 피부감염증 증가 요인으로는 비위생적인 생활습관, 면역력 저하, 환경오염물질 노출, 항생제 내성, 불충분한 상처 관리 등을 들 수 있습니다. 매크로라이드계 항생제는 황색포도상구균이나 화농성 연쇄상구균과 같은 박테리아에 의한 피부 감염, 특히 페니실린 알레르기나 내성이 있는 경우에 자주 처방됩니다. 예를 들어, 2022년 9월 영국 보건안전청(UKHSA)에 따르면, 피부 및 연조직 감염으로 인한 메티실린 내성 황색포도상구균(MRSA) 균혈증 환자 비율은 2020년 4월-2021년 3월과 2021년 4월-2022년 3월 사이에 25.7%에서 33.7%로 증가했습니다. 마찬가지로 메티실린 감수성 황색포도상구균(MSSA) 균혈증도 같은 기간 27.2%에서 28.5%로 증가해 피부감염증 증가 추세가 매크로라이드계 항생제 시장을 견인하고 있습니다.
매크로라이드계 항생제 시장의 주요 기업들은 접근성 향상, 치료 비용 절감, 시장 입지 확대를 위해 제네릭 제제 개발에 점점 더 많은 노력을 기울이고 있습니다. 매크로라이드계 항생제 제네릭 의약품은 활성 성분, 용량, 강도는 오리지널 의약품과 동일하지만 일반적으로 더 낮은 가격으로 판매되고 있습니다. 예를 들어, 미국에 본사를 둔 제약회사 팬텀 파마슈티컬스(Phantom Pharmaceuticals)는 2022년 5월 성인 헬리코박터 파일로리(헬리코박터 파일로리균) 감염을 치료하기 위해 설계된 두 가지 신제품 'VOQUEZNA TRIPLE PAK'과 'VOQUEZNA DUAL PAK'을 출시하였습니다. VOQUEZNA TRIPLE PAK에는 vonoprazan(칼륨 경쟁형 산성 차단제, PCAB), 아목시실린, 클라리스로마이신이, VOQUEZNA DUAL PAK에는 vonoprazan과 아목시실린이 함유되어 있습니다. 보노프라잔의 도입은 미국에서 30년 만에 승인된 새로운 계열의 제산제로서 중요한 진전을 의미합니다. 제네릭으로의 전환은 환자의 치료 접근성 및 구매 편의성을 개선하고, 매크로라이드계 항생제 시장을 확대하는 데 도움이 될 것입니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 신종 코로나바이러스 감염증, 그리고 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계 매크로라이드계 항생제 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 매크로라이드계 항생제 시장 : 성장률 분석
세계의 매크로라이드계 항생제 시장 실적 : 규모와 성장, 2019-2024
세계의 매크로라이드계 항생제 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계 매크로라이드계 항생제 전체 시장(TAM)
제6장 시장 세분화
세계의 매크로라이드계 항생제 시장 : 약물별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
아지트로마이신
클래리트로마이신
에리트로마이신
피닥소미신
텔리트로마이신
세계의 매크로라이드계 항생제 시장 : 적응증별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
호흡기 감염증
피부 감염증
성감염증
위장 감염증
기타 적응증
세계의 매크로라이드계 항생제 시장 : 투여 경로별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
경구
비경구
기타 투여 경로
세계의 매크로라이드계 항생제 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원 약국
드럭스토어와 약국
온라인 프로바이더
세계의 매크로라이드계 항생제 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원
피부과 클리닉
클리닉
외래 센터
조사실
세계의 매크로라이드계 항생제 시장, 아지트로마이신 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
경구정
경구 현탁액
주사
세계의 매크로라이드계 항생제 시장, 클래리트로마이신 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
즉방정
서방정
경구 현탁액
세계의 매크로라이드계 항생제 시장, 에리트로마이신 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
태블릿
캡슐
국소 용액
주사
세계의 매크로라이드계 항생제 시장, 피닥소미신 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
경구정
세계의 매크로라이드계 항생제 시장, 테리트로마이신 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
경구정
제7장 지역별·국가별 분석
세계의 매크로라이드계 항생제 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 매크로라이드계 항생제 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
매크로라이드계 항생제 시장 : 경쟁 구도
매크로라이드계 항생제 시장 : 기업 개요
Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
Merck Sharp & Dohme Corp Overview, Products and Services, Strategy and Financial Analysis
AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
Bayer AG Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Sanofi S.A
Bristol-Myers Squibb Company
Abbott Laboratories
Novartis AG
GlaxoSmithKline plc.
Eli Lily and Company
Amgen Inc.
Teva Pharmaceutical Industries Limited
Mylan N.V.
Daiichi Sankyo
Sun Pharmaceutical Industries Limited
Cipla Limited
Lupin Limited
Zydus Lifesciences Limited
Alkem Laboratories Ltd.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
매크로라이드계 항생제 시장 2029 : 새로운 기회를 제공하는 국가
매크로라이드계 항생제 시장 2029 : 새로운 기회를 제공하는 부문
매크로라이드계 항생제 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
ksm
영문 목차
영문목차
Macrolide antibiotics are characterized by a macrocyclic lactone ring to which one or more sugars are attached. They exert their antibacterial effect by binding to the 50S ribosomal subunit, thereby inhibiting bacterial protein synthesis. This mechanism makes them effective against a wide range of Gram-positive bacteria and some Gram-negative bacteria.
Azithromycin, clarithromycin, erythromycin, fidaxomicin, and telithromycin are the main types of macrolide antibiotics. Azithromycin, for instance, inhibits bacterial growth by disrupting protein synthesis. It is used to treat respiratory tract infections, skin infections, sexually transmitted infections, gastrointestinal infections, among others. Azithromycin can be administered orally, parenterally, or through other routes. It is distributed through hospital pharmacies, retail drug stores, and online providers, and is utilized by various end users such as hospitals, dermatology clinics, outpatient clinics, ambulatory centers, and research laboratories.
The macrolide antibiotics market research report is one of a series of new reports from The Business Research Company that provides macrolide antibiotics market statistics, including macrolide antibiotics industry global market size, regional shares, competitors with a macrolide antibiotics market share, detailed macrolide antibiotics market segments, market trends and opportunities, and any further data you may need to thrive in the macrolide antibiotics industry. This macrolide antibiotics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The macrolide antibiotics market size has grown rapidly in recent years. It will grow from $59.07 billion in 2024 to $66.02 billion in 2025 at a compound annual growth rate (CAGR) of 11.8%. The growth in the historic period can be attributed to increasing antibiotic resistance, approvals for new formulations, a rise in infectious diseases, and government and healthcare initiatives.
The macrolide antibiotics market size is expected to see rapid growth in the next few years. It will grow to $102.09 billion in 2029 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to a rise in respiratory infections due to factors like arise in respiratory infections, rise in combination therapies, an increase in the global geriatric population, increased awareness and diagnostics, and growth in telemedicine and online pharmacy services. Major trends in the forecast period include advancements in drug delivery systems and formulations, the development of novel macrolide antibiotics, advancements in telemedicine and remote healthcare services, and the development of eco-friendly manufacturing processes for macrolide antibiotics.
The growth of the macrolide antibiotics market is expected to be driven by the increasing prevalence of skin infections in the coming years. Skin infections occur when harmful microorganisms invade the skin, causing inflammation and often accompanied by symptoms such as redness, swelling, and pain. Factors contributing to the rise in skin infections include poor hygiene practices, compromised immune systems, exposure to environmental pollutants, antibiotic resistance, and inadequate wound care. Macrolide antibiotics are commonly prescribed to treat skin infections caused by bacteria such as Staphylococcus aureus or Streptococcus pyogenes, especially in cases of penicillin allergy or resistance. For example, according to the UK Health Security Agency (UKHSA) in September 2022, the percentage of Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia cases attributed to skin and soft tissue infections increased from 25.7% to 33.7% between April 2020 to March 2021 and April 2021 to March 2022. Similarly, for Methicillin-Sensitive Staphylococcus aureus (MSSA) bacteremia cases, the percentage rose from 27.2% to 28.5% over the same period, indicating a rising trend in skin infections driving the macrolide antibiotics market.
Major companies in the macrolide antibiotic market are increasingly focusing on developing generic formulations to improve accessibility, reduce treatment costs, and expand their market presence. Generic versions of macrolide antibiotics contain the same active ingredients, dosage, and strength as their branded counterparts but are typically sold at lower prices. For example, in May 2022, Phantom Pharmaceuticals, a US-based pharmaceutical company, launched two new products-VOQUEZNA TRIPLE PAK and VOQUEZNA DUAL PAK-designed to treat Helicobacter pylori (H. pylori) infection in adults. The VOQUEZNA TRIPLE PAK contains vonoprazan (a potassium-competitive acid blocker or PCAB), amoxicillin, and clarithromycin, while the VOQUEZNA DUAL PAK includes vonoprazan and amoxicillin. The introduction of vonoprazan marks a significant advancement, as it represents the first new class of acid suppressants approved in the U.S. in over 30 years. This move towards generic formulations helps improve treatment accessibility and affordability for patients while expanding the market for macrolide antibiotics.
In April 2024, Aztiq, an Iceland-based long-term investment fund, acquired Alvogen Emerging Markets Holdings Limited from PTT Public Company Limited for an undisclosed sum. The acquisition aims to accelerate Adalvo's growth and expansion by leveraging the combined strengths of Aztiq and Innobic (Asia), PTT's wholly-owned Life Science arm. Adalvo, a US-based pharmaceutical company, specializes in providing macrolide antibiotics.
Major companies operating in the macrolide antibiotics market are Pfizer Inc., Roche Holding AG, Merck Sharp & Dohme Corp, AbbVie Inc., Bayer AG, Sanofi S.A, Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc., Eli Lily and Company, Amgen Inc., Teva Pharmaceutical Industries Limited, Mylan N.V., Daiichi Sankyo, Sun Pharmaceutical Industries Limited, Cipla Limited, Lupin Limited, Zydus Lifesciences Limited, Alkem Laboratories Ltd., Zhejiang Guobang Pharmaceutical Co. Ltd., Fresenius Kabi USA, WOCKHARDT, Crescent Pharma Limited, Wellona Pharma Private Limited
North America was the largest region in the macrolide antibiotics market in 2024. The regions covered in the macrolide antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the macrolide antibiotics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The macrolide antibiotics market consists of sales of oral tablets and capsules such as dirithromycin, josamycin, spiramycin, and roxithromycin. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Macrolide Antibiotics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on macrolide antibiotics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for macrolide antibiotics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The macrolide antibiotics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Drugs: Azithromycin; Clarithromycin; Erythromycin; Fidaxomicin; Telithromycin
2) By Indication: Respiratory Tract Infections; Skin Infections; Sexually Transmitted Infections; Gastrointestinal Infections; Other Indications
3) By Route Of Administration: Oral; Parenteral; Other Route Of Administrations
4) By Distribution Channel: Hospital Pharmacies; Drug Stores And Retail Pharmacies; Online Providers
5) By End User: Hospital; Dermatology Clinic; Clinic; Ambulatory Centre; Research Laboratories
Subsegments:
1) By Azithromycin: Oral Tablets; Oral Suspension; Injection
2) By Clarithromycin: Immediate-Release Tablets; Extended-Release Tablets; Oral Suspension
3) By Erythromycin: Tablets; Capsules; Topical Solution; Injection
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Macrolide Antibiotics Market Characteristics
3. Macrolide Antibiotics Market Trends And Strategies
4. Macrolide Antibiotics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Macrolide Antibiotics Growth Analysis And Strategic Analysis Framework
5.1. Global Macrolide Antibiotics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Macrolide Antibiotics Market Growth Rate Analysis
5.4. Global Macrolide Antibiotics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Macrolide Antibiotics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Macrolide Antibiotics Total Addressable Market (TAM)
6. Macrolide Antibiotics Market Segmentation
6.1. Global Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Azithromycin
Clarithromycin
Erythromycin
Fidaxomicin
Telithromycin
6.2. Global Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Respiratory Tract Infections
Skin Infections
Sexually Transmitted Infections
Gastrointestinal Infections
Other Indications
6.3. Global Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Parenteral
Other Route Of Administrations
6.4. Global Macrolide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Drug Stores And Retail Pharmacies
Online Providers
6.5. Global Macrolide Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital
Dermatology Clinic
Clinic
Ambulatory Centre
Research Laboratories
6.6. Global Macrolide Antibiotics Market, Sub-Segmentation Of Azithromycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Tablets
Oral Suspension
Injection
6.7. Global Macrolide Antibiotics Market, Sub-Segmentation Of Clarithromycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immediate-Release Tablets
Extended-Release Tablets
Oral Suspension
6.8. Global Macrolide Antibiotics Market, Sub-Segmentation Of Erythromycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tablets
Capsules
Topical Solution
Injection
6.9. Global Macrolide Antibiotics Market, Sub-Segmentation Of Fidaxomicin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Tablets
6.10. Global Macrolide Antibiotics Market, Sub-Segmentation Of Telithromycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Tablets
7. Macrolide Antibiotics Market Regional And Country Analysis
7.1. Global Macrolide Antibiotics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Macrolide Antibiotics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Macrolide Antibiotics Market
9.1. China Macrolide Antibiotics Market Overview
9.2. China Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Macrolide Antibiotics Market
10.1. India Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Macrolide Antibiotics Market
11.1. Japan Macrolide Antibiotics Market Overview
11.2. Japan Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Macrolide Antibiotics Market
12.1. Australia Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Macrolide Antibiotics Market
13.1. Indonesia Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Macrolide Antibiotics Market
14.1. South Korea Macrolide Antibiotics Market Overview
14.2. South Korea Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Macrolide Antibiotics Market
15.1. Western Europe Macrolide Antibiotics Market Overview
15.2. Western Europe Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Macrolide Antibiotics Market
16.1. UK Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Macrolide Antibiotics Market
17.1. Germany Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Macrolide Antibiotics Market
18.1. France Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Macrolide Antibiotics Market
19.1. Italy Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Macrolide Antibiotics Market
20.1. Spain Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Macrolide Antibiotics Market
21.1. Eastern Europe Macrolide Antibiotics Market Overview
21.2. Eastern Europe Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Macrolide Antibiotics Market
22.1. Russia Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Macrolide Antibiotics Market
23.1. North America Macrolide Antibiotics Market Overview
23.2. North America Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Macrolide Antibiotics Market
24.1. USA Macrolide Antibiotics Market Overview
24.2. USA Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Macrolide Antibiotics Market
26.1. South America Macrolide Antibiotics Market Overview
26.2. South America Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Macrolide Antibiotics Market
27.1. Brazil Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Macrolide Antibiotics Market
28.1. Middle East Macrolide Antibiotics Market Overview
28.2. Middle East Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Macrolide Antibiotics Market
29.1. Africa Macrolide Antibiotics Market Overview
29.2. Africa Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Macrolide Antibiotics Market Competitive Landscape And Company Profiles
